NCT06561061
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Jinja Hospital Jinja, Uganda
Clinical trial condition
Anemia
Explore clinical trials studying Anemia. Study availability and eligibility vary by location and protocol.
2,225 public trials
353 recruiting studies
Anemia trial results
NCT01891812
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
- Locations
-
- New York Presbyterian Morgan Stanley Children's Hospital New York, United States
NCT06835335
- Conditions
- Agnosia, Anemia, Anemia, Hemolytic, +22 more
- Locations
-
- CHU de Nîmes Nîmes, Occitanie, France
- Manchester University NHS FT Manchester, United Kingdom
Completed
L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity
NCT05470998
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Tanta university Tanta, Other (Non U.s.), Egypt
NCT01374360
- Conditions
- Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
- Locations
-
- Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for worldwide locations. Boston, Massachusetts, United States
NCT05879224
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +18 more
- Locations
-
- Puskesmas Hanura Hanura, Lampung, Indonesia
- Puskesmas Tanjung Leidong Labuhanbatu, North Sumatra, Indonesia
- Puskesmas Bhintuka Mimika, Special Region of Papua, Indonesia
- Puskesmas Pasar Sentral Mimika, Special Region of Papua, Indonesia
NCT03817957
- Conditions
- Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +7 more
- Locations
-
- Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital of Goethe-University Frankfurt, Hessia, Germany
NCT02961218
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- Novartis Investigative Site Atlanta, Georgia, United States
- Novartis Investigative Site Augusta, Georgia, United States
- Novartis Investigative Site Greenville, North Carolina, United States
- Novartis Investigative Site Toronto, Ontario, Canada
Completed
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism
NCT03938454
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- University of Connecticut Health Center Farmington, Connecticut, United States
- Childrens National Hospital Washington D.C., District of Columbia, United States
- Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
NCT04328727
- Conditions
- Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
- Locations
-
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Zhengzhou, Henan, China
- Novartis Investigative Site Nanchang, Jiangxi, China
- Novartis Investigative Site Changchun, Jilin, China